Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Jenna Burton to Retrospective Studies

This is a "connection" page, showing publications Jenna Burton has written about Retrospective Studies.

 
Connection Strength
 
 
 
0.179
 
  1. Al-Nadaf S, Rebhun RB, Curran KM, Venable RO, Skorupski KA, Willcox JL, Burton JH. Retrospective analysis of doxorubicin and prednisone as first-line therapy for canine B-cell lymphoma. BMC Vet Res. 2018 Nov 20; 14(1):356.
    View in: PubMed
    Score: 0.039
  2. Gemignani F, Mayhew PD, Giuffrida MA, Palaigos J, Runge JJ, Holt DE, Robertson NA, Seguin B, Walker M, Singh A, Liptak JM, Romanelli G, Martano M, Boston SE, Lux C, Busetto R, Culp WTN, Skorupski KA, Burton JH. Association of surgical approach with complication rate, progression-free survival time, and disease-specific survival time in cats with mammary adenocarcinoma: 107 cases (1991-2014). J Am Vet Med Assoc. 2018 Jun 01; 252(11):1393-1402.
    View in: PubMed
    Score: 0.037
  3. Burton JH, Powers BE, Biller BJ. Clinical outcome in 20 cases of lingual hemangiosarcoma in dogs: 1996-2011. Vet Comp Oncol. 2014 Sep; 12(3):198-204.
    View in: PubMed
    Score: 0.025
  4. Parker AS, Burton JH, Curran KM, Wolf-Ringwall A, Thamm DH. Early progression during or after cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy indicates poor outcome with rescue protocols in dogs with multicentric lymphoma. J Vet Intern Med. 2024 Jul-Aug; 38(4):2282-2292.
    View in: PubMed
    Score: 0.014
  5. Burge R, Woolard KD, Willcox JL, Rebhun RB, Burton JH, Al-Nadaf S, Skorupski KA. High-Grade, Stage 2 Mast Cell Tumors: Outcome in Dogs With Local and Systemic Therapy. J Am Anim Hosp Assoc. 2023 Jul 01; 59(4):167-176.
    View in: PubMed
    Score: 0.013
  6. Yang NS, Johnson EG, Palm CA, Burton JH, Rebhun RB, Kent MS, Culp WTN. MRI characteristics of canine prostatic neoplasia. Vet Radiol Ultrasound. 2023 Jan; 64(1):105-112.
    View in: PubMed
    Score: 0.013
  7. Brady RV, Rebhun RB, Skorupski KA, Burton JH, Al-Nadaf S, Choi E, Willcox JL. Retrospective immunohistochemical investigation of suspected non-visceral leiomyosarcoma in dogs. J Vet Diagn Invest. 2022 May; 34(3):465-473.
    View in: PubMed
    Score: 0.012
  8. Griffin MA, Culp WTN, Giuffrida MA, Ellis P, Tuohy J, Perry JA, Gedney A, Lux CN, Milovancev M, Wallace ML, Hash J, Mathews K, Liptak JM, Selmic LE, Singh A, Palm CA, Balsa IM, Mayhew PD, Steffey MA, Rebhun RB, Burton JH, Kent MS. Lower urinary tract transitional cell carcinoma in cats: Clinical findings, treatments, and outcomes in 118 cases. J Vet Intern Med. 2020 Jan; 34(1):274-282.
    View in: PubMed
    Score: 0.010
  9. Halsey CHC, Thamm DH, Weishaar KM, Burton JH, Charles JB, Gustafson DL, Avery AC, Ehrhart EJ. Expression of Phosphorylated KIT in Canine Mast Cell Tumor. Vet Pathol. 2017 05; 54(3):387-394.
    View in: PubMed
    Score: 0.009
  10. Selmic LE, Burton JH, Thamm DH, Withrow SJ, Lana SE. Comparison of carboplatin and doxorubicin-based chemotherapy protocols in 470 dogs after amputation for treatment of appendicular osteosarcoma. J Vet Intern Med. 2014 Mar-Apr; 28(2):554-63.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)